Listing of the Shares. At the Time of Sale, the Company will have filed an application for listing of the Shares on Nasdaq. The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Shares under the Exchange Act, delisting the Common Shares from Nasdaq, nor has the Company received any notification that the Commission or Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.
Appears in 2 contracts
Samples: Equity Distribution Agreement (Enveric Biosciences, Inc.), Edesa Biotech, Inc.
Listing of the Shares. At the Time of Sale, the Company Shares will have filed an application been approved for listing of the Shares on Nasdaq. The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Shares under the Exchange Act, delisting the Common Shares from Nasdaq, nor has the Company received any notification that the Commission or Nasdaq is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance with all applicable listing requirements of Nasdaq.
Appears in 2 contracts
Samples: Equity Distribution Agreement (Edesa Biotech, Inc.), Edesa Biotech, Inc.
